Jupiter Life Line Hospitals Ltd
(NSE:JLHL)
₹
301.4
-6.05 (-1.97%)
Market Cap: 98.84 Bil
Enterprise Value: 99.28 Bil
PE Ratio: 54.58
PB Ratio: 6.40
GF Score: 71/100 
Q1 2027 Jupiter Life Line Hospitals Ltd Earnings Call Transcript
Aug 03, 2026 / 04:30AM GMT
Release Date Price:
₹319
(-3.77%)
Key Points
Positve
- Dombivali Hospital completed its first full quarter of operations with warm reception from patients and the medical community, contributing to a 9.5 crore EBITDA drag in line with expectations.
- Total income for Q1 FY27 stood at 411 crores, with EBITDA at 79.3 crores (19.3% margin) and PAT at 37.5 crores, reflecting solid financial performance.
- ARPOB grew 10% year-over-year, driven by case mix improvement and ongoing contract renegotiations with insurance companies, indicating strong pricing power.
- The company maintains a strong balance sheet with roughly 500 crores of debt and 500 crores of cash, resulting in zero net debt, and expects internal accruals to fund most of the upcoming CapEx.
- Management has a clear ramp-up strategy for new hospitals, with EBITDA losses only anticipated in the first 1-2 years, followed by margin compression but no losses during subsequent capacity expansions.
- The acquisition of an IV fluids manufacturing unit is a strategic backward integration for the pharmacy subsidiary, aimed at cost management and margin improvement, without shifting the company's core focus.
- Pune and Indore hospitals have occupancy opportunities (mid-60% and ~50% respectively), which should drive faster growth compared to the mature Thane unit.
- Dombivali's occupancy is ramping up month-on-month, and the completion of insurance empanelment is expected to reduce patient friction and further boost occupancy.
- The company has a strong long-term vision, focusing on Western India where there is a significant demand-supply gap for organized healthcare, with three new projects on track.
- Management is cautious with guidance, preferring to wait for more data before revising Dombivali's breakeven timeline, which reflects prudent and conservative planning.
Negative
- Dombivali Hospital is currently operating at a loss, with a 9.5 crore EBITDA drag in Q1 FY27, and fixed costs are expected to increase as doctor hiring continues for the next couple of years.
- Indore hospital's EBITDA margin was lower at 12% due to higher HR-related costs and new doctor hires, which are expected to weigh on profitability in the near term.
- Thane hospital, with occupancy around 75%, has limited growth potential beyond inflationary pricing, which could constrain overall revenue growth.
- The company's overall occupancy rate was diluted to 59.6% due to the expanded bed base at Dombivali, which is still ramping up.
- Dombivali's payer mix is currently dominated by self-pay patients, with insurance empanelment still incomplete, creating friction that limits occupancy growth.
- Management did not provide a specific timeline for Dombivali's breakeven, maintaining the earlier guidance of 1.5-2 years, which may disappoint investors expecting faster progress.
- The company's growth is expected to slow as Pune and Thane mature, with only inflationary growth anticipated for mature units, potentially leading to lower revenue growth rates.
- There is a potential for increased debt towards the end of the current CapEx cycle, which could impact the balance sheet if not managed carefully.
- The BKC hospital location, while premium, may face high operational costs, and the company has not yet provided detailed financial projections for this project.
- The company's focus on Western India may limit diversification, and any regional economic or competitive pressures could disproportionately impact performance.
Operator
Ladies and gentlemen, good day and welcome to the Jupiter Lifeline Hospitals Limited Q1 FY27 ONIX conference call. As a reminder, all participant lines will be in the listen-only mode
( Operators Instructions ) I now hand the conference over to Dr. Ankit Chakkar, Managing Director and CEO.
Thank you and over to you, sir.
Ankit Thakker
Jupiter Life Line Hospitals Ltd - Chief Executive Officer
Good morning, everyone.
Thank you for joining us this Monday morning for our earnings call for Q1 FY '27.
I hope you all had a chance to view our financial results and investor presentation which were posted on the company's website and the stock exchanges.
I am joined today by Mr. Anand Apte, our Chief of Business and Strategy, Mr. Aditya Gupta, our Senior VP of Corporate Affairs, Mr. Nitin Patodi, our Head of Finance, and our Investor Relations Advisors.
The key update from this quarter is that Dombivali Hospital has completed its first full quarter of operations. The reception from both the patient and the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers